Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Standardization and consistency for in-vitro diagnostics is of crucial importance, and the analysis and examination of blood samples is no exception. The Aerospray ® Hematology Pro Slide ...
Hosted on MSN
CellaVision to Present Q3 2025 Report on November 6
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. CellaVision AB ( (SE:CEVI)) has issued an ...
Quarterly Performance Highlights CellaVision reported net sales of SEK 191 million for Q2 2025, representing a modest 1.9% increase from SEK 188 million in the same period last year. While organic ...
Organic sales growth: Q2, 2025: 7.6% (9.9) EBITDA margin: Q2, 2025: 31% (32) April 1 - June 30, 2025 Net sales increased by 1.9% (10.7) to SEK 191 m (188). Sales increased organically by 7.6% (9.9), ...
CellaVision AB (STO:CEVI) reported its second-quarter 2025 results on July 18, showing organic growth of 7.6% despite facing significant currency headwinds. The company’s stock rose 1.44% to SEK 183.2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback